Hirata M, Futaguchi S, Odaguchi K, Inouye K, Tanaka A
Acta Endocrinol (Copenh). 1981 Apr;96(4):464-9. doi: 10.1530/acta.0.0960464.
Tissue distribution of (Aib1, Lys17, 18, 19)-corticotrophin-(1-19)-nonadecapeptide amide (690024-S), iv injected to hypophysectomized rats, were surveyed by bioassay. Among the tissues examined. the largest amount of 690024-S was found in the liver during 3 h of search for the injection, while a higher concentration of the peptide per tissue weight was found in kidney. Though a small amount of 690024-S was detected in spleen, heart and lung at an early stage, it was not detectable in other tissues such as brain, stomach, small intestine, thigh muscle, fat or foetus. The peptide was found to be excreted into bile for the duration of about 2 h. It was also found that the elimination of 690024-S in blood followed biphasic first order kinetics.
通过生物测定法研究了向垂体切除大鼠静脉注射(Aib1、Lys17、18、19)-促肾上腺皮质激素-(1-19)-十九肽酰胺(690024-S)后的组织分布。在所检查的组织中,在注射后3小时的搜索过程中,肝脏中发现的690024-S量最大,而每组织重量中该肽的浓度在肾脏中更高。尽管在早期在脾脏、心脏和肺中检测到少量的690024-S,但在其他组织如脑、胃、小肠、大腿肌肉、脂肪或胎儿中未检测到。发现该肽在约2小时内排泄到胆汁中。还发现血液中690024-S的消除遵循双相一级动力学。